| Dr Taylor Harrison Polk, MD | |
|
2200 Crow Ln, Myrtle Beach, SC 29577-1663 | |
| (843) 848-5300 | |
| (843) 848-5305 |
| Full Name | Dr Taylor Harrison Polk |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 2200 Crow Ln, Myrtle Beach, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093343584 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 90484 (South Carolina) | Primary |
| Entity Name | Georgetown Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982604021 PECOS PAC ID: 8224942123 Enrollment ID: O20031114000600 |
News Archive
Oncolytics Biotech Inc. announced today that enrollment has begun in a 2-Arm randomized Phase II study of carboplatin, paclitaxel plus REOLYSIN versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer.
It reads like a who's who of the next generation of Republican Party leaders: Marco Rubio, Ted Cruz, Rob Portman. But what is bringing all these marquee political names together is not the Iowa State Fair or a Tea Party rally on the National Mall. Rather, they are all talking discreetly about how to advance a bill in the Senate to ban abortion at 20 weeks after fertilization (Peters, 7/27).
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported preliminary unaudited financial results for the quarter ended September 30, 2011.
A new delivery method for levodopa/carbidopa, a common dual-drug Parkinson's disease (PD) regimen, significantly improved the duration of the drugs' effectiveness in people with advanced PD, according to research by Mount Sinai School of Medicine.
› Verified 8 days ago
| Entity Name | Waccamaw Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972503910 PECOS PAC ID: 9133036932 Enrollment ID: O20031126000386 |
News Archive
Oncolytics Biotech Inc. announced today that enrollment has begun in a 2-Arm randomized Phase II study of carboplatin, paclitaxel plus REOLYSIN versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer.
It reads like a who's who of the next generation of Republican Party leaders: Marco Rubio, Ted Cruz, Rob Portman. But what is bringing all these marquee political names together is not the Iowa State Fair or a Tea Party rally on the National Mall. Rather, they are all talking discreetly about how to advance a bill in the Senate to ban abortion at 20 weeks after fertilization (Peters, 7/27).
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported preliminary unaudited financial results for the quarter ended September 30, 2011.
A new delivery method for levodopa/carbidopa, a common dual-drug Parkinson's disease (PD) regimen, significantly improved the duration of the drugs' effectiveness in people with advanced PD, according to research by Mount Sinai School of Medicine.
› Verified 8 days ago
| Entity Name | Georgetown Physician Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235475930 PECOS PAC ID: 2365697398 Enrollment ID: O20130225000067 |
News Archive
Oncolytics Biotech Inc. announced today that enrollment has begun in a 2-Arm randomized Phase II study of carboplatin, paclitaxel plus REOLYSIN versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer.
It reads like a who's who of the next generation of Republican Party leaders: Marco Rubio, Ted Cruz, Rob Portman. But what is bringing all these marquee political names together is not the Iowa State Fair or a Tea Party rally on the National Mall. Rather, they are all talking discreetly about how to advance a bill in the Senate to ban abortion at 20 weeks after fertilization (Peters, 7/27).
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported preliminary unaudited financial results for the quarter ended September 30, 2011.
A new delivery method for levodopa/carbidopa, a common dual-drug Parkinson's disease (PD) regimen, significantly improved the duration of the drugs' effectiveness in people with advanced PD, according to research by Mount Sinai School of Medicine.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Taylor Harrison Polk, MD 2200 Crow Ln, Myrtle Beach, SC 29577-1663 Ph: (843) 848-5300 | Dr Taylor Harrison Polk, MD 2200 Crow Ln, Myrtle Beach, SC 29577-1663 Ph: (843) 848-5300 |
News Archive
Oncolytics Biotech Inc. announced today that enrollment has begun in a 2-Arm randomized Phase II study of carboplatin, paclitaxel plus REOLYSIN versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer.
It reads like a who's who of the next generation of Republican Party leaders: Marco Rubio, Ted Cruz, Rob Portman. But what is bringing all these marquee political names together is not the Iowa State Fair or a Tea Party rally on the National Mall. Rather, they are all talking discreetly about how to advance a bill in the Senate to ban abortion at 20 weeks after fertilization (Peters, 7/27).
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported preliminary unaudited financial results for the quarter ended September 30, 2011.
A new delivery method for levodopa/carbidopa, a common dual-drug Parkinson's disease (PD) regimen, significantly improved the duration of the drugs' effectiveness in people with advanced PD, according to research by Mount Sinai School of Medicine.
› Verified 8 days ago
Gary A Vukov, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 7900 N Kings Hwy, Myrtle Beach, SC 29572 Phone: 843-449-3381 Fax: 843-839-0275 | |
Gregory L Becker, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 906 Medical Cir, Myrtle Beach, SC 29572 Phone: 843-497-5929 Fax: 843-839-1037 | |
Andrew Peter Mangano, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 920 Doug White Dr Ste 250, Myrtle Beach, SC 29572 Phone: 843-236-1950 Fax: 843-236-1952 | |
Dr. Eunice Luz Guzman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4220 Carolina Exchange Dr, Myrtle Beach, SC 29579 Phone: 843-663-8371 | |
Jacob Hurlan Brazee, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4301 Dick Pond Rd, Myrtle Beach, SC 29588 Phone: 843-652-8100 Fax: 843-652-8122 | |
Dr. Emily Zaruhi Touloukian, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8121 Rourk St, Myrtle Beach, SC 29572 Phone: 843-692-5000 | |
Dr. Jocelyn A Myers, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 945 82nd Pkwy, Myrtle Beach, SC 29572 Phone: 843-497-5929 |